FDA - Food and Drug Administration

09/04/2026 | Press release | Distributed by Public on 09/04/2026 07:33

Business Pill, Branch Manager for Men (dietary supplements marketed for male sexual enhancement/SUPPLX.com) Recall reason: Products contain undeclared yohimbine

COMPANY ANNOUNCEMENT

SUPPLX.com Issues Voluntary Nationwide Recall of Business Pill and Branch Manager for Men Due to Undeclared Yohimbine

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement View Product Photos

Summary

Company Announcement Date: September 03, 2026 FDA Publish Date: September 04, 2026 Product Type: Dietary Supplements
Food & Beverages Reason for Announcement:
Recall Reason Description
Products contain undeclared yohimbine
Company Name: SUPPLX.com Brand Name:
Brand Name(s)
Business Pill, Branch Manager for Men
Product Description:
Product Description
dietary supplements marketed for male sexual enhancement

Company Announcement

Grant-Valkaria, Florida - SUPPLX.com is voluntarily recalling Business Pill and Branch Manager for Men, products marketed as dietary supplements for male sexual enhancement, because FDA laboratory analysis confirmed that both products contain yohimbine that is not declared on the product labels.

Yohimbine is a plant-derived alkaloid formulated for use as a prescription medication, generally as a treatment for erectile dysfunction. It has also been studied for use to promote blood flow and support athletic performance. FDA found dangerously high levels of yohimbine in the recalled products. Yohimbine can cause severe hypertension, tachycardia, and possibly cardiac arrhythmia and myocardial infarction (heart attacks), especially if the consumer is taking other stimulants such as caffeine or ephedra-containing products or prescription drugs used to treat ADHD. Severe gastrointestinal distress, including nausea, vomiting, diarrhea and stomach pain are typical side effects of high doses. It can also cause acute neurologic and psychiatric effects, including anxiety, insomnia, mania, psychosis in schizophrenic patients, drowsiness, disorientation, tremors and seizures. Death has been reported in cases of severe overdose.

The recalled products were packaged in single-capsule blister cards and sold in 24-count retail boxes through SUPPLX.com. The recall covers all lots and expiration or best-by dates distributed from September 16, 2023, through June 11, 2026. Lot and expiration or best-by information appears on the back of each individual blister card. On Business Pill, it appears in the upper-right corner; on Branch Manager for Men, it appears directly above the barcode. No other SUPPLX.com products are included in this recall.

SUPPLX.com is notifying affected customers directly. Consumers who possess Business Pill or Branch Manager for Men should stop using the product immediately and dispose of any remaining product. Consumers who have experienced health problems that may be related to use of either product should contact a physician or other health care provider.

Consumers with questions may contact SUPPLX Recall at (321) 341-9501 or [email protected].

Health care professionals and consumers are encouraged to report adverse events or side effects related to use of these products to FDA's MedWatch Safety Information and Adverse Event Reporting Program online at www.fda.gov/medwatch/report.htm or by fax at 1-800-FDA-0178.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Company Contact Information

Consumers: SUPPLX Recall (321) 341-9501 [email protected]

Product Photos

FDA - Food and Drug Administration published this content on September 04, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 04, 2026 at 13:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]